- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Congress map
Accreditation

IMCAS World Congress 2016
Program

SESSION 48

Clinical dermatology: drug delivery clinical indication risks

Room: Room 7
Date: Friday 29 January 2016 at 16:00 to 17:00
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chairs

Dr James Q DEL ROSSO

Dermatologist

United States

Dr Anne LE PILLOUER

Dermatologist

France

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
16:00	Prof Uwe PAASCH	Benefits, risks, side effects and potential complications of device-assisted drug delivery	View	27648
16:24	Dr Rolf Markus SZEIMIES	Intensified PDT	View	34432
16:36	Dr Diane Irvine DUNCAN	Microneedling: a cost effective way to deliver drugs intradermally		37688
16:48		Questions & answers		29156

Go to previous session

Go to next session

Recommended sessions

Drug delivery

Lasers

Complications

Microneedling

Photodynamic therapy (PDT)

Prof Uwe PAASCH

Dermatologist

Germany

Other author(s) :

Benefits, risks, side effects and potential complications of device-assisted drug delivery

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Rolf Markus SZEIMIES

Dermatologist

Germany

Other author(s) :

Intensified PDT

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Diane Irvine DUNCAN

Plastic Surgeon

United States

Other author(s) :

Microneedling: a cost effective way to deliver drugs intradermally

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Questions & answers

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS World Congress 2016 Program

SESSION 48

Clinical dermatology: drug delivery clinical indication risks

Chairs

Lectures of the session

Recommended sessions

IMCAS World Congress 2016
Program